59 filings
Page 2 of 3
8-K
5e3so4mu
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
8-K
zpb1 el99w0xlak5g
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
lpf607tea3b445wc
26 Sep 23
Other Events
9:33am
8-K
5vz6 m4hl
20 Sep 23
Amendments to Articles of Incorporation or Bylaws
5:16pm
8-K
65ut3w
8 Sep 23
Submission of Matters to a Vote of Security Holders
2:30pm
8-K
7hzp fbevu8tmcbj
30 Aug 23
Entry into a Material Definitive Agreement
4:35pm
8-K
namp5 tuakca16frh94
24 Aug 23
Regulation FD Disclosure
5:15pm
8-K
mxp1i5j
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
8-K
uzhp01l twk15
7 Aug 23
Entry into a Material Definitive Agreement
8:23pm
8-K
8tnrf0n
2 Aug 23
Changes in Registrant's Certifying Accountant
4:19pm
8-K
m14ht eutf63cnjew
30 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:06pm
8-K
2t7omi18kjb
16 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
5a2bfl
9 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
7f3o35jz
16 May 23
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
ih73dhsndq gp9n
9 May 23
SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device
5:02pm
8-K
pzym7zlykbeiy4
30 Mar 23
SeaStar Medical Reports 2022 Financial Results and Provides a Business Update
9:58pm
8-K
gtri42y
16 Mar 23
SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement
8:30am
8-K
hxk1u1oksh648yf5loh1
15 Feb 23
Regulation FD Disclosure
12:00am
8-K
zgf p0q0erwm1
9 Feb 23
SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to
4:06pm
8-K
zkemrs5vyh4303n
9 Jan 23
Other Events
8:32am